Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
431-01-015 / 431-01-015 ISMRM Abstract

Amsterdam Imaging and Clinical Glioma Database; IMAGO release 1.0

Primary: Neuro - Tumors
Secondary: Analysis Methods - Data Processing
431-01-015 · From Microstructure to Metabolism: Next-Generation MRI for Brain Tumors · Tuesday, 12 May, 8:20 AM–9:56 AM · Roof Terrace
431-01-015 · From Microstructure to Metabolism: Next-Generation MRI for Brain Tumors · Tuesday, 12 May, 8:20 AM–9:56 AM · Roof Terrace
Keywords: Segmentation Open-Source Adult-type diffuse glioma Prediction Imaging database
Accepted
Ivar Wamelink 1,2, Alle Meije Wink3,4, Niels Verburg5, Roelant S Eijgelaar5, Emmanouil Koltsakis6,7, Marcus Cakmak1, Maarten Balder1, Henk J Mutsaerts1,4, Philip de Witt Hamer5, Mathilde Kouwenhoven2,8, Pieter Wesseling9,10, Frederik Barkhof1,2,11, Vera C Keil1,2,4
1Radiology and Nuclear Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
4Brain Imaging, Amsterdam Neuroscience, Amsterdam, Netherlands
5Department of Neurosurgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
6Radiology, Karolinska University Hospital, Stockholm, Sweden
7Clinical Science, Intervention, and Technology, Karolinska Institutet, Solna, Sweden
8Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
9Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
10Princes Máxima Center for Pediatric Oncology, Netherlands
11Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, United Kingdom
Presenting Author: Ivar Wamelink

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Henriksen OM, Del Mar Álvarez-Torres M, Figueiredo P, Hangel G, Keil VC, Nechifor RE, et al. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques. Front Oncol. 2022;12: 810263. doi:10.3389/fonc.2022.810263 [doi]
2. Booth TC, Wiegers EC, Warnert EAH, Schmainda KM, Riemer F, Nechifor RE, et al. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics. Front Oncol. 2021;11: 811425. doi:10.3389/fonc.2021.811425 [doi]
3. Vollmuth P, Foltyn M, Huang RY, Galldiks N, Petersen J, Isensee F, et al. Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study. Neuro Oncol. 2023;25: 533–543. doi:10.1093/neuonc/noac189 [doi]
4. Ghadimi DJ, Vahdani AM, Karimi H, Ebrahimi P, Fathi M, Moodi F, et al. Deep learning-based techniques in glioma brain tumor segmentation using multi-parametric MRI: A review on clinical applications and future outlooks. J Magn Reson Imaging. 2025;61: 1094–1109. doi:10.1002/jmri.29543 [doi]
5. Moya-Sáez E, de Luis-García R, Alberola-López C. Toward deep learning replacement of gadolinium in neuro-oncology: A review of contrast-enhanced synthetic MRI. Frontiers in Neuroimaging. 2023;2. doi:10.3389/fnimg.2023.1055463 [doi]
6. Baid U, Ghodasara S, Mohan S, Bilello M, Calabrese E, Colak E, et al. The RSNA-ASNR-MICCAI BraTS 2021 benchmark on brain tumor segmentation and radiogenomic classification. arXiv [cs.CV]. 2021. Available: http://arxiv.org/abs/2107.02314
7. Menze BH, Jakab A, Bauer S, Kalpathy-Cramer J, Farahani K, Kirby J, et al. The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS). IEEE Trans Med Imaging. 2015;34: 1993–2024. doi:10.1109/TMI.2014.2377694 [doi]
8. Bakas S, Akbari H, Sotiras A, Bilello M, Rozycki M, Kirby JS, et al. Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features. Sci Data. 2017;4: 170117. doi:10.1038/sdata.2017.117 [doi]
9. Scarpace L, Mikkelsen T, Cha S, Rao S, Tekchandani S, Gutman D, et al. Radiology Data from The Cancer Genome Atlas Glioblastoma Multiforme [TCGA-GBM] collection [Data set]. The Cancer Imaging Archive. 2016. doi:10.7937/K9/TCIA.2016.RNYFUYE9 [doi]
10. van der Voort SR, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, et al. The Erasmus Glioma Database (EGD): Structural MRI scans, WHO 2016 subtypes, and segmentations of 774 patients with glioma. Data Brief. 2021;37: 107191. doi:10.1016/j.dib.2021.107191 [doi]
11. Calabrese E, Villanueva-Meyer JE, Rudie JD, Rauschecker AM, Baid U, Bakas S, et al. The university of California San Francisco preoperative diffuse glioma MRI dataset. Radiol Artif Intell. 2022;4: e220058. doi:10.1148/ryai.220058 [doi]
12. Ivar J.H.G Wamelink, Alle Meije Wink, Niels Verburg, Roeland S Eijgelaar, Emmanouil Koltsakis, Marcus Cakmak, Maarten Balder, Henk J.M.M Mutsaerts, Philip Witt Hamer Frederik Barkhof, Vera C. Keil. IMAGO. Amsterdam Imaging and Clinical Glioma database. 2025. Available: https://catalogue.eucaim.cancerimage.eu/Eucaim/eucaim-ui/#/dataset/imago
13. Ivar Wamelink, Joost Kuijer, Vera Keil, Frederik Barkhof, Alle Meije Wink. CINDERELLA: Computerised INference and DERivation of MRI sequence Linguistic Labelling Algorithm. OHBM.
14. Rohlfing T, Zahr NM, Sullivan EV, Pfefferbaum A. The SRI24 multichannel atlas of normal adult human brain structure. Hum Brain Mapp. 2010;31: 798–819. doi:10.1002/hbm.20906 [doi]
15. Pemberton HG, Wu J, Kommers I, Müller DMJ, Hu Y, Goodkin O, et al. Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms. Sci Rep. 2023;13: 18911. doi:10.1038/s41598-023-44794-0 [doi]
16. Helland RH, Ferles A, Pedersen A, Kommers I, Ardon H, Barkhof F, et al. Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks. Sci Rep. 2023;13: 18897. doi:10.1038/s41598-023-45456-x [doi]
17. Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18: 203–211. doi:10.1038/s41592-020-01008-z [doi]
18. Kickingereder P, Isensee F, Tursunova I, Petersen J, Neuberger U, Bonekamp D, et al. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. Lancet Oncol. 2019;20: 728–740. doi:10.1016/S1470-2045(19)30098-1 [doi]
19. Isensee F, Jäger PF, Kohl SAA, Petersen J, Maier-Hein KH. Automated design of deep learning methods for biomedical image segmentation. arXiv [cs.CV]. 2019. Available: http://arxiv.org/abs/1904.08128
20. Gupta R, Flanagan S, Li CCY, Lee M, Shivalingham B, Maleki S, et al. Expanding the spectrum of IDH1 mutations in gliomas. Mod Pathol. 2013;26: 619–625. doi:10.1038/modpathol.2012.210 [doi]
21. Sahm F, Brandner S, Bertero L, Capper D, French PJ, Figarella-Branger D, et al. Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. Neuro Oncol. 2023;25: 1731–1749. doi:10.1093/neuonc/noad100 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/431-01-015